Skip to main content
Equibles
CRBP logo

CRBP · Corbus Pharmaceuticals Holdings, Inc.

Track CRBP — free

Use CRBP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CRBP

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$10.35 +0.26 (+2.58%)
Market Cap
$195.15M
Shares
19.34M

Corbus Pharmaceuticals Holdings, Inc. Earnings Call Transcripts

Every quarterly earnings call for Corbus Pharmaceuticals Holdings, Inc. (CRBP) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲33.5% $2.57M −$26.58M '19 Q4 20-03-12 ▼6.6% $1.76M −$29.66M '20 Q1 20-05-11 ▼99% $286,346 −$38.11M '20 Q2 20-08-06 ▼52.5% $1.23M −$34.90M '20 Q3 20-11-10 LATEST ▼74.4% $658,204 −$8.61M '20 Q4 21-03-15
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-26
Pre-2026 ASCO Conference Call & Webcast
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY20 · Q4
2021-03-15
Corbus Pharmaceuticals Holdings, Inc. Q4 FY2020 Earnings Call
Revenue
$658,204*
▼ 74.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Corbus Pharmaceuticals Holdings, Inc. Q3 FY2020 Earnings Call
Revenue
$1.23M
▼ 52.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Corbus Pharmaceuticals Holdings, Inc. Q2 FY2020 Earnings Call
Revenue
$286,346
▼ 99% YoY
Diluted EPS
$-15.60
▼ 1833.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Corbus Pharmaceuticals Holdings, Inc. Q1 FY2020 Earnings Call
Revenue
$1.76M
▼ 6.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-12
Corbus Pharmaceuticals Holdings, Inc. Q4 FY2019 Earnings Call
Revenue
$2.57M*
▲ 33.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–7 of 7 earnings calls
Key facts CIK 1595097 CUSIP 21833P301 13F (30d) 102 filings 100 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)